MedPath

Outcomes Data of Bone Marrow Stem Cells to Treat Hip and Knee Osteoarthritis

Completed
Conditions
Hip and Knee Osteoarthritis
Interventions
Other: Procedural, Bone Marrow concentrate injection
Registration Number
NCT01601951
Lead Sponsor
Regenerative Pain Center, Illinois
Brief Summary

The purpose of this study is to determine if Bone Marrow Concentrate may be successful in the treatment of osteoarthritis. Bone Marrow Concentrate is known to contain a community of cells that has been shown to have "regenerative" properties. This study is designed to evaluate the short-term clinical and x-ray outcomes of injections for hip and knee osteoarthritis.

Inclusion Criteria:

* Subjects must be scheduled for an autologous bone marrow hip or knee injection

* Subjects must have a diagnosis of hip or knee osteoarthritis

* Subjects must be between the ages of 18 and 85

* Subjects must be willing and able to sign Informed Consent

* Subjects must be willing and able to return for scheduled follow-up evaluations

Exclusion Criteria:

* Subjects who have had any type of visco-supplementation in the treated joint within the last three months prior to enrollment

* Subjects for whom baseline data is not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Subjects must be scheduled for an autologous bone marrow hip or knee injection
  • Subjects must have a diagnosis of hip or knee osteoarthritis
  • Subjects must be between the ages of 18 and 85
  • Subjects must be willing and able to sign Informed Consent
  • Subjects must be willing and able to return for scheduled follow-up evaluations
Exclusion Criteria
  • Subjects who have had any type of visco-supplementation in the treated joint within the last three months prior to enrollment
  • Subjects for whom baseline data is not available

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Hip OsteoarthritisProcedural, Bone Marrow concentrate injection-
Knee OsteoarthritisProcedural, Bone Marrow concentrate injection-
Primary Outcome Measures
NameTimeMethod
Visual Analog Pain ScaleBaseline, 6 weeks, 3 months, 1 year

Change in subjective pain measure

Harris Hip Score or Knee Society ScoreBaeline, 6 weeks, 3 months, 1 year

Change in subjective pain, function, functional activity measurement and a clinical physical exam

Physician Global AssessmentBaseline, 6 weeks, 3 months, 1 year

Change in physician rated disease activity measurement

Secondary Outcome Measures
NameTimeMethod
RadiologicBaseline, 1 year

Radiographic changes of the hip or knee

Trial Locations

Locations (1)

Regenerative Pain Center

🇺🇸

Des Plaines, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath